3D IntelliGenes: AI/ML application using multi-omics data for biomarker discovery and disease prediction with multi-dimensional visualization
Narayanan, R.; Peker, E.; Degroat, W.; Mendhe, D.; Zeeshan, S.; Ahmed, Z.
Show abstract
BackgroundThe cutting-edge AI/ML techniques have proven effective at uncovering elucidative knowledge on disease-causing biomarkers and the biological underpinnings of a plethora of human diseases. However, the high-dimensional nature of multi-omics data presents numerous challenges in its effective presentation, annotation, and interpretation. Traditional 2D visualizations often fall short in capturing the intricate relationships between multi-omics features, hindering our ability to identify meaningful correlations. MethodsIn this study, we focused on addressing such challenges by developing an innovative solution to better visualize results produced by AI/ML approaches on integrated clinical and multi-omics data for novel biomarker discovery and predictive analysis. We present an advanced version of our earlier published software with intuitive and interactive visualizations of multi-omics data in multi-dimensions i.e., 3D IntelliGenes, which offers deeper insights, most importantly by capturing greater variability in the patient data by understanding both linear and non-linear structures, evaluating AI/ML model performance, and delineating the joint impact of biomarkers on the corresponding disease states. ResultsThe overall functionality of 3D IntelliGenes is divided into two modules, data clustering and feature plotting. The data clustering module creates configurable 3D scatter plots to visualize the structure-preserving distribution of disease states, AI/ML classifier bias in the form of type I/II errors, and patient similarity through a robust density-driven clustering algorithm. Whereas the feature plotting module supports the joint analysis of pairs of multi-omics features to analyze the interdependence and discriminative power of co-expressed biomarkers. ConclusionWe report evaluated performance of 3D IntelliGenes using diverse cohorts of patients with cardiovascular and other diseases.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- VICTOR: A visual analytics web application for comparing cluster sets 95%
- Unsupervised Discovery of Risk Profiles on Negative and Positive COVID-19 Hospitalized Patients 94%
- Enrichment analysis on regulatory subspaces: a novel direction for the superior description of cellular responses to SARS-CoV-2 93%
Similar papers in this journal
- DeepInsight-3D for precision oncology: an improved anti-cancer drug response prediction from high-dimensional multi-omics data with convolutional neural networks 94%
- Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method 93%
- Machine learning for classifying chronic kidney disease and predicting creatinine levels using at-home measurements 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.